Non-destructive inhibition of metallofullerenol Gd@C82(OH) 22 on WW domain: Implication on signal transduction pathway

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Kang, Seung Gu ^a   Huynh, Tien ^a   Zhou, Ruhong ^a,b  

^a IBM T J WATSON RESEARCH CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; FULLERENE DERIVATIVE; GELATINASE A; GELATINASE B; LIGAND; PROTEIN KINASE YES; YES1 PROTEIN, HUMAN;

ARTICLE; BINDING SITE; BIOSYNTHESIS; CHEMISTRY; DOWN REGULATION; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; METABOLISM; MOLECULAR DYNAMICS; NEOPLASM; PROLINE RICH PROTEIN DOMAIN; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; BINDING SITES; CONTRAST MEDIA; DOWN-REGULATION; EXTRACELLULAR MATRIX; FULLERENES; HUMANS; LIGANDS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MOLECULAR DYNAMICS SIMULATION; NEOPLASMS; PROLINE-RICH PROTEIN DOMAINS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-YES; SIGNAL TRANSDUCTION;

EID: 84871807890     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00957     Document Type: Article

References (45)

1. Kroto, H. W., Heath, J. R., Obrien, S. C., Curl, R. F. & Smalley, R. E. C60: Buckminsterfullerene. Nature 318, 162-163 (1985).
2. Guldi,D.M., Rahman, A., Sgobba, V. &Ehli, C. Multifunctional molecular carbon materials - from fullerenes to carbon nanotubes. Chem. Soc. Rev. 35, 471-487 (2006). (Pubitemid 44004949)
3. Mateo-Alonso, A., Guldi, D. M., Paolucci, F. & Prato, M. Fullerenes: Multitask components in molecular machinery. Angew. Chem., Int. Ed. 46, 8120-8126 (2007). (Pubitemid 350096582)
4. Anilkumar, P. et al. Fullerenes for Applications in Biology and Medicine. Curr. Med. Chem. 18, 2045-2059 (2011).
5. Davis, M. E., Chen, Z. G. & Shin, D. M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discovery 7, 771-782 (2008).
6. Xia, T., Li, N. & Nel, A. E. Potential health impact of nanoparticles. Annu. Rev. Public Health 30, 137-150 (2009).
7. Gilbert, N. Nanoparticle safety in doubt. Nature 460, 937 (2009).
8. Porter, A. E. et al. Direct imaging of single-walled carbon nanotubes in cells. Nat. Nanotechnol. 2, 713-717 (2007). (Pubitemid 350071068)
9. Zhang, B. et al. Functionalized carbon nanotubes specifically bind to alphachymotrypsin's catalytic site and regulate its enzymatic function. Nano Lett. 9, 2280-2284 (2009).
10. Ge, C. et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 108, 16968-16973 (2011).
11. Sayes, C. M. et al. The differential cytotoxicity of water-soluble fullerenes. Nano Lett. 4, 1881-1887 (2004).
12. Sayes, C. M., Marchione, A. A., Reed, K. L. & Warheit, D. B. Comparative pulmonary toxicity assessments of C-60 water suspensions in rats: Few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano Lett. 7, 2399-2406 (2007). (Pubitemid 47310138)
13. Kamat, J. P., Devasagayam, T. P., Priyadarsini, K. I. &Mohan, H. Reactive oxygen species mediated membrane damage induced by fullerene derivatives and its possible biological implications. Toxicology 155, 55-61 (2000). (Pubitemid 32056314)
14. Johnston, H. J., Hutchison, G. R., Christensen, F. M., Aschberger, K. & Stone, V. The Biological Mechanisms and Physicochemical Characteristics Responsible for Driving Fullerene Toxicity. Toxicol. Sci. 114, 162-182 (2010).
15. Chen, C. et al. Multihydroxylated [Gd@C82(OH)22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity. Nano Lett. 5, 2050-2057 (2005). (Pubitemid 41546336)
16. Meng, H. et al. Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: imprisoning instead of poisoning cancer cells. Nanomedicine 8, 136-146 (2012).
17. Meng, H. et al. Potent angiogenesis inhibition by the particulate form of fullerene derivatives. ACS Nano 4, 2773-2783 (2010).
18. Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249-257 (2000).
19. Kang, S.-G. et al.Molecular mechanism of pancreatic tumor metastases inhibition by Gd@C82(OH)22: Implication for de novo design of nanomedicine. Proc. Natl. Acad. Sci. U. S. A. 109, 15431-15436 (2012).
20. Mikawa, M. et al. Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjugate Chem. 12, 510-514 (2001). (Pubitemid 32704179)
21. Kato, H. et al. Lanthanoid endohedral metallofullerenols for MRI contrast agents. J. Am. Chem. Soc. 125, 4391-4397 (2003). (Pubitemid 36512335)
22. Sudol, M., Sliwa, K. & Russo, T. Functions ofWWdomains in the nucleus. FEBS Lett. 490, 190-195 (2001).
23. Ingham, R. J. et al. WW domains provide a platform for the assembly of multiprotein networks. Mol. Cell. Biol. 25, 7092-7106 (2005). (Pubitemid 41105907)
24. Pires, J. R. et al. Solution structures of the YAP65WWdomain and the variant L30 K in complex with the peptides GTPPPPYTVG, N-(n-octyl)-GPPPY and PLPPY and the application of peptide libraries reveal a minimal binding epitope. J. Mol. Biol. 314, 1147-1156 (2001). (Pubitemid 34073077)
25. Macias, M. J. et al. Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide. Nature 382, 646-649 (1996).
26. Zuo, G.,Huang, Q.,Wei, G., Zhou, R.&Fang, H. Plugging into proteins: poisoning protein function by a hydrophobic nanoparticle. ACS Nano 4, 7508-7514 (2010).
27. Toepert, F., Pires, J. R., Landgraf, C., Oschkinat, H. & Schneider-Mergener, J. Synthesis of an Array Comprising 837 Variants of the hYAP WW Protein Domain. Angew. Chem., Int. Ed. 40, 897-900 (2001). (Pubitemid 32225496)
28. Kumar, S. et al. Scalable molecular dynamics with NAMD on the IBM Blue Gene/L system. IBM J. Res. Dev. 52, 177-188 (2008). (Pubitemid 351386010)
29. Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926-935 (1983).
30. MacKerell, A. D. et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 102, 3586-3616 (1998).
31. Macias, M. J., Wiesner, S. & Sudol, M. WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett. 513, 30-37 (2002). (Pubitemid 34242975)
32. Zhou, R., Berne, B. J. & Germain, R. The free energy landscape for beta hairpin folding in explicit water. Proc. Natl. Acad. Sci. U. S. A. 98, 14931-14936 (2001). (Pubitemid 34013947)
33. Wade, R. C., Gabdoulline, R. R., Ludemann, S. K. & Lounnas, V. Electrostatic steering and ionic tethering in enzyme-ligand binding: insights from simulations. Proc. Natl. Acad. Sci. U. S. A. 95, 5942-5949 (1998). (Pubitemid 28248943)
34. Yang, Z., Wang, Z., Tian, X., Xiu, P. & Zhou, R. Amino acid analogues bind to carbon nanotube via pi-pi interactions: comparison of molecular mechanical and quantum mechanical calculations. J. Chem. Phys. 136, 025103 (2012).
35. Woolf, T. B., Grossfield, A. & Pearson, J. G. Indoles at interfaces: Calculations of electrostatic effects with density functional and molecular dynamics methods. Int. J. Quantum Chem. 75, 197-206 (1999). (Pubitemid 129648060)
36. Ball, L. J., Kuhne, R., Schneider-Mergener, J. & Oschkinat, H. Recognition of proline-rich motifs by protein-protein-interaction domains. Angew. Chem., Int. Ed. 44, 2852-2869 (2005). (Pubitemid 40689661)
37. Zhang, W. et al. Biosafety assessment of Gd@C82(OH)22 nanoparticles on Caenorhabditis elegans. Nanoscale 3, 2636-2641 (2011).
38. Yagi, R., Chen, L. F., Shigesada, K., Murakami, Y. & Ito, Y. A WW domaincontaining yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J. 18, 2551-2562 (1999). (Pubitemid 29213286)
39. Levy, D., Adamovich, Y., Reuven, N.&Shaul, Y. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol. Cell 29, 350-361 (2008). (Pubitemid 351215937)
40. Sudol, M. Structure and function of theWWdomain. Prog. Biophys. Mol. Biol. 65, 113-132 (1996).
41. Salah, Z., Alian, A. & Aqeilan, R. I. WW domain-containing proteins: retrospectives and the future. Front. Biosci. 17, 331-348 (2012).
42. Ibragimova, G. T. &Wade, R. C. Stability of the beta-sheet of theWWdomain: A molecular dynamics simulation study. Biophys. J. 77, 2191-2198 (1999). (Pubitemid 29463179)
43. Ozkan, S. B.,Wu, G. A., Chodera, J. D. &Dill, K. A. Protein folding by zipping and assembly. Proc. Natl. Acad. Sci. U. S. A. 104, 11987-11992 (2007). (Pubitemid 47185617)
44. Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: An Nlog(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089-10092 (1993).
45. Phillips, J. C. et al. Scalable molecular dynamics with NAMD. J. Comput. Chem. 26, 1781-1802 (2005).